medonline
Posts for keyword:

CMP-001

CMP-001
Mohammed Milhem on the combination of CMP-001 + Pembro
Mohammed Milhem presents preliminary data on the combination of the TLR9 agonist CMP-001 and pembrolizumab in patients with metastatic melanoma resistant to anti-PD-1.
CMP-001
Combination CMP-001 + Pembro in anti-PD-1-resistant melanoma
TLR9 agonist CMP-001-pembrolizumab combination shows early efficacy in patients with metastatic melanoma resistant to anti-PD-1.